Pharmacokinetics and toxicity of antimuscarinic drugs for overactive bladder treatment in females

By Leone Roberti Maggiore Umberto   Salvatore Stefano   Alessandri Franco   Remorgida Valentino   Origoni Massimo   Candiani Massimo   Venturini Pier Luigi   Ferrero Simone  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 8, Iss. 11, 2012-11 ,pp. : 1387-1408

Informa Healthcare

Access to resources Recommend Favorite

Cost implications of antimuscarinic drugs in the treatment of overactive bladder syndrome

By Perimenis Petros   Konstantinopoulos Angelis   Giannitsas Konstantinos   Athanasopoulos Anastasios  

Expert Opinion on Pharmacotherapy, Vol. 7, Iss. 5, 2006-04 ,pp. : 539-544

Informa Healthcare

Access to resources Recommend Favorite

Pharmacotherapy for Overactive Bladder: An Evidence-Based Approach to Selecting an Antimuscarinic Agent

By Appell Rodney A.  

Drugs, Vol. 66, Iss. 10, 2006-01 ,pp. : 1361-1370

Adis International

Access to resources Recommend Favorite

The antimuscarinic agent solifenacin succinate can significantly improve symptoms of overactive bladder

By  

Inpharma, Vol. 1, Iss. 1430, 2004-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite

Antimuscarinic Treatment in Overactive Bladder: Special Considerations in Elderly Patients

By Wagg Adrian S.  

Drugs & Aging, Vol. 29, Iss. 7, 2012-07 ,pp. : 539-548

Adis International

Access to resources Recommend Favorite